CytoMed Therapeutics Ltd (GDTC)
1.98
+0.06
(+3.12%)
USD |
NASDAQ |
Jun 21, 16:00
1.96
-0.02
(-1.01%)
Pre-Market: 20:00
CytoMed Therapeutics Cash and Short Term Investments (Quarterly): 6.810M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.810M |
| June 30, 2023 | 7.696M |
| June 30, 2023 | 7.696M |
| December 31, 2022 | 1.178M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.068M |
| June 30, 2022 | 1.068M |
| December 31, 2021 | 1.858M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.068M
Minimum
Jun 2022
7.696M
Maximum
Jun 2023
3.910M
Average
1.858M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Haw Par Corp Ltd | 2.430B |
| WAVE Life Sciences Ltd | 180.92M |
| ASLAN Pharmaceuticals Ltd | 18.40M |
| EUDA Health Holdings Ltd | 0.3205M |
| Mobile-health Network Solutions | 2.547M |